CMND
NASDAQ · Pharmaceuticals
Clearmind Medicine Inc
$0.69
+0.02 (+3.46%)
Open$0.72
Previous Close$0.67
Day High$0.72
Day Low$0.67
52W High$52.40
52W Low$0.59
Volume—
Avg Volume294.8K
Market Cap1.38M
P/E Ratio—
EPS$-30.64
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 523.5K | 483.3K | 576.6K |
| Net Income | 68.9K | 73.1K | 95.7K |
| Profit Margin | 13.2% | 15.1% | 16.6% |
| EBITDA | 118.6K | 102.7K | 135.6K |
| Free Cash Flow | 93.6K | 59.2K | 119.0K |
| Rev Growth | +19.2% | +7.8% | +18.0% |
| Debt/Equity | 0.43 | 0.45 | 0.38 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |